HomeNRIX • NASDAQ
add
Nurix Therapeutics Inc
Previous close
$9.14
Day range
$9.17 - $9.97
Year range
$8.18 - $29.56
Market cap
750.92M USD
Avg Volume
1.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | 18.45M | 11.26% |
Operating expense | 11.65M | -1.23% |
Net income | -56.35M | -35.73% |
Net profit margin | -305.38 | -21.99% |
Earnings per share | -0.67 | 11.84% |
EBITDA | -60.51M | -40.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 549.68M | 125.29% |
Total assets | 615.04M | 96.70% |
Total liabilities | 134.13M | -6.81% |
Total equity | 480.92M | — |
Shares outstanding | 76.24M | — |
Price to book | 1.45 | — |
Return on assets | -24.47% | — |
Return on capital | -29.57% | — |
Cash Flow
Net change in cash
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -56.35M | -35.73% |
Cash from operations | -61.09M | -45.62% |
Cash from investing | 25.53M | -28.10% |
Cash from financing | 1.47M | -9.30% |
Net change in cash | -34.08M | -607.96% |
Free cash flow | -38.64M | -114.96% |
About
Founded
2009
Headquarters
Website
Employees
286
